ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

EKF Ekf Diagnostics Holdings Plc

27.40
0.00 (0.00%)
19 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Ekf Diagnostics Holdings Plc LSE:EKF London Ordinary Share GB0031509804 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 27.40 27.10 28.60 27.40 27.40 27.40 260,265 16:21:02
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Med, Dental, Hosp Eq-whsl 66.64M -10.1M -0.0222 -12.34 124.65M

EKF Diagnostics Holdings PLC Director/PDMR Shareholding (0971A)

21/03/2017 1:47pm

UK Regulatory


Ekf Diagnostics (LSE:EKF)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Ekf Diagnostics Charts.

TIDMEKF

RNS Number : 0971A

EKF Diagnostics Holdings PLC

21 March 2017

EKF Diagnostics Holdings plc

("EKF", the "Company")

PDMR dealing

EKF Diagnostics Holdings plc (AIM: EKF) announces that on 21 March 2017, the Company was notified that Harwood Capital LLP ("Harwood") acquired 8,000,000 ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares") as investment manager to North Atlantic Smaller Companies Investment Trust PLC ("NAIT"). Christopher Mills, the Company's Non-Executive Chairman, is a partner and Chief Investment Officer of Harwood and a director and shareholder in NAIT.

Following the above transaction, which was completed on 20 March 2017 at a price of 19.5p pence per share, NAIT's interest is now in 98,000,000 Ordinary Shares, representing 21.12% of the Company's issued share capital. The interests of Oryx International Growth Fund Limited ("Oryx", whose investment adviser is Harwood) remains as previously disclosed in 40,000,000 Ordinary Shares, representing 8.62% of the Company's issued share capital. Mr Mills is also a director and shareholder in Oryx.

The total indirect beneficial interest of Mr Mills is, following the above transaction, therefore now in 138,000,000 Ordinary Shares, representing 29.73% of the Company's issued share capital.

 
     EKF Diagnostics Holdings plc                             www.ekfdiagnostics.com 
     Christopher Mills, Non-Executive                             Tel: 029 2071 0570 
      Chairman 
     Julian Baines, CEO 
     Richard Evans, FD & COO 
 
     N+1 Singer (Nomad & Broker)                                  Tel: 020 7496 3000 
     Alex Price / Shaun Dobson 
      / Alex Laughton-Scott 
 
     Walbrook PR Limited                    Tel: 020 7933 8780 or ekf@walbrookpr.com 
     Paul McManus / Lianne Cawthorne              Mob: 07980 541 893 / 07584 391 303 
 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 
     1        Details of the person discharging managerial 
               responsibilities / person closely associated 
-------  ------------------------------------------------------------------------- 
     a)       Name                           Harwood Capital LLP, as investment 
                                              manager to North Atlantic Smaller 
                                              Companies Investment Trust PLC 
                                              ("NAIT") 
-------  -----------------------------  ------------------------------------------ 
     2        Reason for the notification 
-------  ------------------------------------------------------------------------- 
     a)       Position/status                Christopher Mills, the Company's 
                                              Non-Executive Chairman, is a partner 
                                              and Chief Investment Officer of 
                                              Harwood Capital LLP and a director 
                                              and shareholder in NAIT 
-------  -----------------------------  ------------------------------------------ 
     b)       Initial notification           Initial Notification 
               /Amendment 
-------  -----------------------------  ------------------------------------------ 
     3        Details of the issuer, emission allowance market 
               participant, auction platform, auctioneer or 
               auction monitor 
-------  ------------------------------------------------------------------------- 
     a)       Name                           EKF Diagnostics Holdings plc 
-------  -----------------------------  ------------------------------------------ 
     b)       LEI                            213800DXTF3EAUK1AR05 
-------  -----------------------------  ------------------------------------------ 
     4        Details of the transaction(s): section to be 
               repeated for (i) each type of instrument; (ii) 
               each type of transaction; (iii) each date; and 
               (iv) each place where transactions have been 
               conducted 
-------  ------------------------------------------------------------------------- 
     a)       Description of                 Ordinary shares of 1p each ("Ordinary 
               the financial                  Shares") 
               instrument, type 
               of instrument 
                                              ISIN Code: GB0031509804 
               Identification 
               code 
-------  -----------------------------  ------------------------------------------ 
     b)       Nature of the                  Acquisition of shares 
               transaction 
-------  -----------------------------  ------------------------------------------ 
     c)       Price(s) and volume(s)               Price(s)       Volume(s) 
                                               -------------  -------------- 
                                                    19.5p          8,000,000 
                                               -------------  -------------- 
-------  -----------------------------  ------------------------------------------ 
     d)       Aggregated information         n/a 
 
 
               - Aggregated volume 
 
 
               - Price 
-------  -----------------------------  ------------------------------------------ 
     e)       Date of the transaction        20 March 2017 
-------  -----------------------------  ------------------------------------------ 
     f)       Place of the transaction       London Stock Exchange 
-------  -----------------------------  ------------------------------------------ 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHBXGDXUSDBGRB

(END) Dow Jones Newswires

March 21, 2017 09:47 ET (13:47 GMT)

1 Year Ekf Diagnostics Chart

1 Year Ekf Diagnostics Chart

1 Month Ekf Diagnostics Chart

1 Month Ekf Diagnostics Chart

Your Recent History

Delayed Upgrade Clock